The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide
✍ Scribed by Giannopoulos, K; Schmitt, M; Własiuk, P; Chen, J; Bojarska-Junak, A; Kowal, M; Roliñski, J; Dmoszyñska, A
- Book ID
- 110058378
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 107 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract B‐cell chronic lymphocytic leukemia (CLL) is characterized by a high rate of clonal genomic alterations and a low proliferative activity with cell cycle arrest in G~0~/G~1~ phase. Recently, centrosome aberrations have been described as a possible cause of chromosomal instability and ane
In the past 5 years a number of cytokines have been identified that control B cell development, proliferation, and maturation. The role of such cytokines in the evolution, pathophysiology, and treatment of B cell malignancies is an area of great interest. The in vitro response of freshly isolated pe